Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Carcinogenesis|September 11, 2019
Applied electric fields suppress osimertinib-induced cytotoxicity via inhibiting FOXO3a nuclear translocation through AKT activationLi Li, Chen Hu, Conghua Lu, et al.Oncotarget|October 27, 2015
Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathwayLi Li, Wenting Huang, Kunlin Li, et al.Cell Death Discovery|April 23, 2022
Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLCConghua Lu, Rui Yu, Chong Zhang, et al.Cell Death & Disease|February 12, 2020
Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1Hengyi Chen, Caiyu Lin, Tao Peng, et al.Oncotarget|December 10, 2017
Caveolin-1-mediated STAT3 activation determines electrotaxis of human lung cancer cellsLi Li, Kejun Zhang, Conghua Lu, et al.Oncotarget|July 3, 2018
Correction: Caveolin-1-mediated STAT3 activation determines electrotaxis of human lung cancer cellsLi Li, Kejun Zhang, Conghua Lu, et al.The Tohoku Journal of Experimental Medicine|January 17, 2024
AXIN1/MYC Axis Mediated the Osimertinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer CellsHaoyue Yu, Zhiguo Wang, Yan Dong, et al.Cancer Letters|March 27, 2019
Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancerLi Li, Yubo Wang, Lin Jiao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2014
Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversalLi Li, Rui Han, Hualiang Xiao, et al.Cancer Letters|February 26, 2024
Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancerRui Han, Caiyu Lin, Conghua Lu, et al.Pageof 4